COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency     
Yazarlar (2)
Makale Türü Diğer (Teknik, not, yorum, vaka takdimi, editöre mektup, özet, kitap krıtiği, araştırma notu, bilirkişi raporu ve benzeri)
Makale Alt Türü SCI, SSCI, AHCI, SCI-Exp dergilerinde yayınlanan teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden makale
Dergi Adı Biomedical Papers
Dergi ISSN 1213-8118 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 03-2021
Cilt No 165
Sayı 1
Sayfalar 1 / 7
DOI Numarası 10.5507/bp.2021.011
Makale Linki https://doi.org/10.5507/bp.2021.011
Özet
The current Coronavirus disease outbreak requires that physicians work in collaboration with other physicians especially in intensive care and emergency units. To fight against this new disease, whose pathogenesis, effects, and results have not been clearly demonstrated, especially in patients with the pre-existing chronic disease, requires special expertise and perspectives. Due to the need for dynamic glucocorticoid treatment at different stages of the disease in patients with adrenal insufficiency, the existence of reports indicating that "coronavirus disease 2019" also affects the adrenal reserve, and the use of glucocorticoids also in advanced stages in patients with Coronavirus disease require this issue to be emphasized with precision. Herein, treatment of the pre-existing adrenal insufficiency in patients with actual Coronavirus disease and the effects of the this critical disease on the adrenal gland have been reviewed.
Anahtar Kelimeler
SARS-CoV-2 | adrenal insufficiency | adrenal cortex | severe acute respiratory syndrome | glucocorticoids
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
WoS 12
COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency

Paylaş